HighTower Advisors
BVS icon

HighTower Advisors’s Bioventus BVS Stock Holding History

HighTower Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
15,412
+251
+2% +$2.4K ﹤0.01% 3602
2026
Q1 		$138K Buy
15,161
+38
+0.3% +$319 ﹤0.01% 3583
2025
Q4 		$113K Sell
15,123
-495
-3% -$3.56K ﹤0.01% 3488
2025
Q3 		$104K Buy
15,618
+2,001
+15% +$13.9K ﹤0.01% 3532
2025
Q2 		$90.1K Hold
13,617
– – ﹤0.01% 3485
2025
Q1 		$125K Hold
13,617
– – ﹤0.01% 3316
2024
Q4 		$143K Buy
13,617
+1,380
+11% +$16.3K ﹤0.01% 3291
2024
Q3 		$145K Hold
12,237
– – ﹤0.01% 3225
2024
Q2 		$71K Buy
+12,237
New +$67.1K ﹤0.01% 3263
2022
Q4 		– Sell
-15,820
Closed -$111K – 3365
2022
Q3 		$111K Hold
15,820
– – ﹤0.01% 2747
2022
Q2 		$109K Buy
15,820
+855
+6% +$8.72K ﹤0.01% 2772
2022
Q1 		$211K Buy
14,965
+2,007
+15% +$26.9K ﹤0.01% 2815
2021
Q4 		$188K Buy
+12,958
New +$184K ﹤0.01% 2797

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HighTower Advisors's BVS Position: Q2 2026 in Review

HighTower Advisors increased its Bioventus (BVS) stake by 1.7% in Q2 2026, buying an estimated $2.4K and bringing the position to 15,412 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

HighTower Advisors first reported a position in BVS in Q4 2021 and has held it in 13 quarters since. The position peaked at $211K in Q1 2022. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • HighTower Advisors held 15,412 shares of Bioventus worth $145K as of Q2 2026.
  • HighTower Advisors bought 251 Bioventus shares in Q2 2026, an estimated $2.4K.
  • Bioventus made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3602 holding.
  • HighTower Advisors first reported a position in Bioventus in Q4 2021 and has held it in 13 quarters since.
  • HighTower Advisors's Bioventus position peaked at $211K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.